Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

A community‐based, cross‐sectional study of hr HPV DNA self‐sampling‐based cervical cancer screening in rural Karnataka, India

Adsul, P., Srinivas, V., Gowda, S., Nayaka, S., Pramathesh, R., Chandrappa, K., Khan, A., Jayakrishna, P., & Madhivanan, P. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12859 · Cited by 23

Prevention of Human Papillomavirus–Associated Cancers

Dillner, J. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.028 · Cited by 23

Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study

Freeman, M., Waller, J., Sasieni, P. D., Lim, A. W., & Marlow, L. A. V. (2018) · Journal of Medical Screening · doi:10.1177/0969141318756452 · Cited by 23

Evaluation of Sensitivity and Specificity of Pap Smear, LBC and HPV in Screening of Cervical Cancer

Pankaj, S., Kumari, A., Kumari, S., Choudhary, V., Kumari, J., Kumari, A., & Nazneen, S. (2018) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-018-0221-x · Cited by 23

Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population

Cho, H., Hong, J. H., Min, K., Ouh, Y., Seong, S. J., Moon, J. H., Cho, S. H., & Lee, J. K. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.1165 · Cited by 23

Inter‐ and intraobserver agreement in whole‐slide digital ThinPrep samples of low‐grade squamous lesions of the cervix uteri with known high‐risk HPV status: A multicentric international study

Kholová, I., Negri, G., Nasioutziki, M., Ventura, L., Capitanio, A., Bongiovanni, M., Cross, P., Bourgain, C., Edvardsson, H., Granados, R., et al. (2022) · Cancer Cytopathology · doi:10.1002/cncy.22624 · Cited by 23

Women’s attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review

Nothacker, J., Nury, E., Mathieu, M. R., Raatz, H., Meerpohl, J. J., & Schmucker, C. M. (2022) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2022-201515 · Cited by 23

Screening comes of age and treatment progress continues

Meijer, C. J. L. M., & Snijders, P. J. F. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.252 · Cited by 23

Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia

Piyathilake, C. J., Badiga, S., Chambers, M. M., Brill, I. K., Matthews, R., & Partridge, E. E. (2016) · Cancer · doi:10.1002/cncr.30123 · Cited by 23

Excellent analytical and clinical performance of a dry self‐sampling device for human papillomavirus detection in an urban Chinese referral population

Chen, K., Ouyang, Y., Hillemanns, P., & Jentschke, M. (2016) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13132 · Cited by 23

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

Andreassen, T., Hansen, B. T., Engesæter, B. Ø., Hashim, D., Støer, N. C., Tropé, A., Moen, K., Ursin, G., & Weiderpass, E. (2018) · International Journal of Cancer · doi:10.1002/ijc.32067 · Cited by 23

A Thematic Analysis of Attitudes Toward Changes to Cervical Screening in Australia

Dodd, R. H., Obermair, H., & McCaffery, K. J. (2019) · JMIR Cancer · doi:10.2196/12307 · Cited by 23

A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China

Li, Y., Ma, L., Yang, C., Chen, Z., Zhao, Y., Dang, L., Lang, J., Qiao, Y., & Executive office, T. H. S. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.05.13 · Cited by 23

Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta‐analysis

Malagón, T., Volesky, K. D., Bouten, S., Laprise, C., El‐Zein, M., & Franco, E. L. (2020) · International Journal of Cancer · doi:10.1002/ijc.33035 · Cited by 23

Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study

Dong, L., Zhang, L., Hu, S., Feng, R., Zhao, X., Zhang, Q., Pan, Q., Zhang, X., Qiao, Y., & Zhao, F. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00853-1 · Cited by 23

HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study

Andersen, B. S., Njor, S. H., Jensen, A. M. S., Johansen, T. O., Jeppesen, U., & Svanholm, H. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-001457 · Cited by 24

Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries

Robles, C., Bruni, L., Acera, A., Riera, J. C., Prats, L., Poljak, M., Mlakar, J., Oštrbenk, A., Eriksson, T., Lehtinen, M., et al. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.08.032 · Cited by 23

The challenges of defining sample adequacy in an era of HPV based cervical screening

Cuschieri, K. S., Wilson, A., Palmer, T. J., Stanczuk, G. A., Bhatia, R., Ejegod, D. M., & Bonde, J. H. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104756 · Cited by 23

Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States

Cuzick, J. M., Du, R., Adcock, R., Kinney, W., Joste, N. E., McDonald, R. M., English, K. C., Torres, S. M., Saslow, D., Wheeler, C. M., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.06.029 · Cited by 24

Prevalence of HPV‐16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high‐risk HPV testing

Tao, X., Zhang, H., Li, J., Zhang, H., Xiao, J., Zhang, L., Zhou, X., Sui, L., Wang, L., & Zhao, C. (2019) · Cancer Cytopathology · doi:10.1002/cncy.22180 · Cited by 23

Cervical cancer screening in older women

Gilham, C., Crosbie, E. J., & Peto, J. (2021) · BMJ · doi:10.1136/bmj.n280 · Cited by 23

Early Cervical Cancer Diagnosis with SWIN-Transformer and Convolutional Neural Networks

Mohammed, F. A., Tune, K. K., Mohammed, J., Wassu, T. A., & Muhie, S. Y. (2024) · Diagnostics · doi:10.3390/diagnostics14202286 · Cited by 22

Enhanced Cervical Cancer Screening: A Sensitive Electrochemical Approach for HPV 18 L1 Protein Detection Using a Gold-Graphitic Carbon Nitride-Based Immunosensor

Lala, A., Kotal, H., Kalyani, T., Bhattacharjee, M., Mandal, R., & Jana, S. K. (2024) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/ad8fd7 · Cited by 22

Prevalence characteristics of high-risk human papillomaviruses in women living in Shanghai with cervical precancerous lesions and cancer

Gu, Y., Ma, C.-Y., Zou, J., Zhu, Y., Rong, Y., Xu, Y., & Zhang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8262 · Cited by 22

ABCD criteria to improve visual inspection with acetic acid (VIA) triage in HPV-positive women: a prospective study of diagnostic accuracy

Petignat, P., Kenfack, B., Wisniak, A., Saïji, E., Tille, J., Fouogue, J. T., Catarino, R., Tincho, E., & Vassilakos, P. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052504 · Cited by 22

Disparities in Diagnosis and Treatment of Cervical Adenocarcinoma Compared With Squamous Cell Carcinoma: An Analysis of the National Cancer Database, 2004–2017

Smith, A. J. B., Beavis, A., Rositch, A. F., & Levinson, K. L. (2022) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000702 · Cited by 22

Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda

Nang, D. W., Tukirinawe, H., Okello, M., Tayebwa, B., Pius, T., Sikakulya, F. K., Fajardo, Y., Afodun, A. M., & Kajabwangu, R. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02342-y · Cited by 24

SEOM-GEICO Clinical Guidelines on cervical cancer (2023)

Manso, L., Vaswani, A. R., Romero, I., Sánchez‐Lorenzo, L., Bermejo-Pérez, M. J., Estévez-García, P., Fariñas-Madrid, L., García, Y. G., Gil-Martín, M., & Quindós, M. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03604-3 · Cited by 23

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions

Bottari, F., Sideri, M. G., Gulmini, C., Igidbashian, S., Tricca, A., Casadio, C., Carinelli, S. G., Boveri, S., Ejegod, D. M., Bonde, J. H., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00246-15 · Cited by 22

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile

Marcela Lagos, L., Wyngard, V. V. D., Helena Poggi, M., Cook, P., Paola Viviani, G., Barriga, M. I., Martha Pruyas, A., & Catterina Ferreccio, R. (2015) · Infectious Agents and Cancer · doi:10.1186/s13027-015-0038-5 · Cited by 22

Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2

Lee, D.-H., Hwang, N. R., Lim, M. C., Yoo, C. W., Joo, J., Kim, J., Park, S., & Hwang, S. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215614036 · Cited by 22

Human papillomavirus test with cytology triage in organized screening for cervical cancer

Veijalainen, O., Kares, S., Kujala, P. M., Tirkkonen, M., Vuento, R., Kholová, I., Luukkaala, T. H., Osuala, V., & Mäenpää, J. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13013 · Cited by 22

Randomised study of HPV prevalence and detection of CIN2+ in vaginal self‐sampling compared to cervical specimens collected by medical personnel

Gustavsson, I. M., Aarnio, R., Berggrund, M., Hedlund‐Lindberg, J., Sanner, K., Wikström, I., Enroth, S., Olovsson, M. H., & Gyllensten, U. B. (2018) · International Journal of Cancer · doi:10.1002/ijc.31637 · Cited by 24

Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology

Yu, K. F., Hyun, N., Fetterman, B. J., Lorey, T. S., Raine‐Bennett, T. R., Zhang, H., Stamps, R. E., Poitras, N. E., Wheeler, W., Befano, B., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy044 · Cited by 22

A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15‐year cervical cancer screening experience at Kaiser Permanente Northern California

Hammer, A., Demarco, M., Campos, N. G., Befano, B., Gravitt, P. E., Cheung, L. C., Lorey, T. S., Poitras, N. E., Kinney, W., Wentzensen, N., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32950 · Cited by 24

Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice

Scagnolari, C., Cannella, F., Pierangeli, A., Mellinger-Pilgrim, R., Antonelli, G., Rowley, D., Wong, M., Best, S. R., Xing, D., Roden, R. B. S., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00087-20 · Cited by 23

Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination

Grimes, D. R., Corry, E., Malagón, T., Ó’Riain, C., Franco, E. L., & Brennan, D. J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.15321 · Cited by 22

Cervical cancer screening in rural Bhutan with the care HPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan)

Baussano, I., Tshering, S., Choden, T., Lazzarato, F., Tenet, V., Plummer, M., Franceschi, S., Clifford, G. M., & Tshomo, U. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016309 · Cited by 22

Transition from opportunistic cytological to organized screening program with DNA-HPV testing detected prevalent cervical cancers 10 years in advance

Teixeira, J. C., Vale, D. B., Campos, C. S., Polegatto, I., Bragança, J. F., Discacciati, M. G., & Zeferino, L. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-71735-2 · Cited by 21

PAX1 / SOX1 DNA Methylation Versus Cytology and HPV16 /18 Genotyping for the Triage of High‐Risk HPV ‐Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples

Chan, K. K. L., Liu, S. S., Lau, L. S. K., Ngu, S., Chu, M. M. Y., Tse, K. Y., Cheung, A., & Ngan, H. (2024) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17965 · Cited by 24

Making Sense of Cervical Cancer Screening Guidelines and Recommendations

Davis, M., & Feldman, S. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0373-1 · Cited by 21

Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay

Catarino, R., Vassilakos, P., Bilancioni, A., Bougel, S., Boukrid, M., Meyer-Hamme, U., & Petignat, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181905 · Cited by 21

Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling?

Lim, A. W. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1538 · Cited by 21

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework

Dhillon, S. K., Oštrbenk, A., Xu, L., Poljak, M., & Arbyn, M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00286-21 · Cited by 21

Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study

Bao, H., Ma, L., Zhao, Y., Song, B., Di, J., Wang, L., Gao, Y., Ren, W., Wang, S., Wu, J., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12256 · Cited by 21

HPV screening in the urine of transpeople - A prevalence study

Pils, S., Mlakar, J., Poljak, M., Domjanič, G. G., Kaufmann, U., Springer, S., Salat, A., Langthaler, E. M., & Joura, E. A. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101702 · Cited by 21

High‐risk HPV testing vs liquid‐based cytology for cervical cancer screening among 25‐ to 30‐year‐old women: A historical cohort study

Feldstein, O., Gali‐Zamir, H., Schejter, E., Feinberg, T., Yehuda‐Shnaidman, E., Bornstein, J., & Levy, T. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14482 · Cited by 21

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening

Verhoef, L., Bleeker, M. C. G., Polman, N. J., Steenbergen, R. D. M., Ebisch, R. M. F., Melchers, W. J. G., Bekkers, R. L. M., Molijn, A. C., Quint, W. G. V., van Kemenade, F. J., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02277-z · Cited by 22

The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions

Jia, C., Wu, Y., Gao, F., Liu, W., Li, N., Yao, C., Sun, L., Wang, S., Yu, C., Bao, Y., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.043 · Cited by 22

Protecting the underscreened women in developed countries: the value of HPV test

Ibáñez, R., Autonell, J., Sardà, M., Crespo, N., Pique, P., Pascual, A. G., Martí, C. D., Fibla, M., Gutiérrez, C., Lloveras, B., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-574 · Cited by 21

Clinical Evaluation of Human Papillomavirus Detection by careHPVTMTest on Physician-Samples and Self-Samples using The Indicating FTA Elute® Card

Wang, S., Hu, S., Chen, F., Chen, W., Zhao, F., Zhang, Y., Ma, X., & Qiao, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.17.7085 · Cited by 21

Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting

Poljak, M., Oštrbenk, A., Seme, K., Šterbenc, A., Jančar, N., & Bokal, E. V. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.021 · Cited by 21

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand

Khunamornpong, S., Settakorn, J., Sukpan, K., Suprasert, P., Srisomboon, J., Intaraphet, S., & Siriaunkgul, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158184 · Cited by 21

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan

Sasaki, Y., Iwanari, O., Arakawa, I., Moriya, T., Mikami, Y., Iihara, K., & Konno, R. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000898 · Cited by 21

Assessment of Cervical Cancer with a Parameter-Free Intravoxel Incoherent Motion Imaging Algorithm

Becker, A. S., Perucho, J. A. U., Wurnig, M. C., Boss, A., Ghafoor, S., Khong, P., & Lee, E. Y. P. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.3.510 · Cited by 21

Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination

Zhu, Y., Wang, Y., Hirschhorn, J. W., Welsh, K. J., Zhao, Z., Davis, M., & Feldman, S. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.01.004 · Cited by 22

Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend

Gervais, F., Dunton, K., Jiang, Y., & Largeron, N. (2017) · BMC Public Health · doi:10.1186/s12889-017-4076-3 · Cited by 22

The Cost-Effectiveness of Visual Triage of Human Papillomavirus–Positive Women in Three Low- and Middle-Income Countries

Campos, N. G., Jerónimo, J., Tsu, V. D., Castle, P. E., Mvundura, M., & Kim, J. J. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0787 · Cited by 21

Implementation Considerations Using HPV Self-Collection to Reach Women Under-Screened for Cervical Cancer in High-Income Settings

Pedersen, H., Smith, L., Racey, C. S., Cook, D. A., Krajden, M., van Niekerk, D., & Ogilvie, G. S. (2018) · Current Oncology · doi:10.3747/co.25.3827 · Cited by 21

Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer

Zhu, S., Zhu, J., Song, Y., Chen, J., Wang, L., Zhou, M., Jiang, P., Li, W., Xue, X., Zhao, K., et al. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9167-2 · Cited by 21

Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing

Lindström, A. K., Hermansson, R. S., Gustavsson, I. M., Lindberg, J. H., Gyllensten, U. B., & Olovsson, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207714 · Cited by 21

Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan

Toyoda, S., Kawaguchi, R., & Kobayashi, H. (2019) · Acta Cytologica · doi:10.1159/000498977 · Cited by 21

Triaging women with human papillomavirus infection and normal cytology or low‐grade dyskaryosis: evidence from 10‐year follow up of the ARTISTIC trial cohort

Gilham, C., Sargent, A., & Peto, J. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15957 · Cited by 21

Epidemiology and analysis of potential risk factors of high‐risk human papillomavirus (HPV) in Shanghai China: A cross‐sectional one‐year study in non‐vaccinated women

Niu, J., Pan, S., Wei, Y., Hong, Z., Gu, L., Di, W. J., & Qiu, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27453 · Cited by 21

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program

Smith, L., Khurshed, F., van Niekerk, D. J., Krajden, M., Greene, S. B., Hobbs, S. H., Coldman, A. J., Franco, E. L., & Ogilvie, G. S. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1060 · Cited by 22

Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme

Pasquale, L., Rossi, P. G., Carozzi, F., Pedretti, C., Ruggeri, C., Scalvinoni, V., Cottini, M., Tosini, A., Morana, C., Chiaramonte, M., et al. (2014) · Journal of Medical Screening · doi:10.1177/0969141314561707 · Cited by 21

Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening

Oštrbenk Valenčak, A., Cuschieri, K., Connor, L., Zore, A., Smrkolj, Š., & Poljak, M. (2024) · Journal of Clinical Virology · doi:10.1016/j.jcv.2023.105638 · Cited by 20

A multimodal deep learning model for cervical pre-cancers and cancers prediction: Development and internal validation study

Madathil, S. A., Dhouib, M., Lelong, Q., Bourassine, A., & Monsonégo, J. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109710 · Cited by 20

A risk-based framework to decide who benefits from screening

Castle, P. E., & Katki, H. A. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.101 · Cited by 20

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

Castañón, A., Landy, R., & Sasieni, P. D. (2016) · Journal of Medical Screening · doi:10.1177/0969141316654197 · Cited by 20

Evaluation of a Chip-Based, Point-of-Care, Portable, Real-Time Micro PCR Analyzer for the Detection of High-Risk Human Papillomavirus in Uterine Cervix in India

Hariprasad, R., Tulsyan, S., Babu, R., Dhanasekaran, K., Thakur, N., Hussain, S., Tripathi, R., Sreenivas, V., Sharma, S. B., Sriram, L., et al. (2020) · JCO Global Oncology · doi:10.1200/go.20.00024 · Cited by 21

Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme

Bennett, K. F., Waller, J., McBride, E., Forster, A. S., Gessa, G. D., Kitchener, H. C., & Marlow, L. A. V. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16460 · Cited by 20

Clearance of HR-HPV within one year after focused ultrasound or loop electrosurgical excision procedure in patients with HSIL under 30

Qin, Y., Li, Q., Ke, X., Zhang, Y., Shen, X., Wang, W., Shi, Q., & Li, C. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.2010817 · Cited by 20

Dual-enzyme cascade amplification electrochemical biosensor for human papillomavirus based on DNA nanoflower structure

He, H., Cheng, L., He, Y., Chen, J., Song, L., Yang, Y., Zhang, Y., Lin, Z., & Hong, G. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132532 · Cited by 20

Photonic Bandgap Fiber Microlaser with Dual‐Band Emission for Integrated Optical Tagging and Sensing

Wang, Y., Gong, C., Yang, X., Zhu, T., Zhang, K., Rao, Y., Wei, L., & Gong, Y. (2023) · Laser & Photonics Review · doi:10.1002/lpor.202200834 · Cited by 20

A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine

Ruan, Y., Li, H., Liu, M., Cao, G., Xu, X., Han, L., & Li, F. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102372 · Cited by 20

Utilization of PAX1 methylation test for cervical cancer screening of non-HPV16/18 high-risk HPV infection in women

Yang, L., Tao, H., Lin, B., He, X., Chen, Y., & Fan, X. (2023) · Future Oncology · doi:10.2217/fon-2023-0226 · Cited by 20

Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study

Tranberg, M., Petersen, L. K., Hammer, A., Elfström, M. K., Blaakær, J., Jørgensen, S. F., Bennetsen, M. H., Jensen, J. S., & Andersen, B. S. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004253 · Cited by 20

Risk assessment to guide cervical screening strategies in a large C hinese population

Zhao, F., Hu, S., Zhang, Q., Zhang, X., Pan, Q., Zhang, W., Gage, J. C., Wentzensen, N., Castle, P. E., Qiao, Y., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30012 · Cited by 20

Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2

SCHIFFMAN, M. H., Yu, K. F., Zuna, R. E., Dunn, S. T., Zhang, H., Walker, J. L., Gold, M. A., Hyun, N., Rydzak, G., Katki, H. A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30456 · Cited by 20

Selection of women at risk for cervical cancer in an HIV-infected South African population

van Zummeren, M., Kremer, W. W., van Aardt, M. C., Breytenbach, E., Richter, K. L., Rozendaal, L., Lissenberg-Witte, B. I., Strooper, L. M. A. D., Hesselink, A. T., Heideman, D. A. M., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001583 · Cited by 20

A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens

Babion, I., Snoek, B. C., van de Wiel, M. A., Wilting, S. M., & Steenbergen, R. D. M. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.04.010 · Cited by 20

Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting

Rendle, K. A. S., SCHIFFMAN, M. H., Cheung, L. C., Kinney, W., Fetterman, B. J., Poitras, N. E., Lorey, T. S., & Castle, P. E. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.12.023 · Cited by 20

HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests

Ge, Y., Mody, R. R., Olsen, R. J., Zhou, H. S., Luna, E., Armylagos, D., Puntachart, N., Hendrickson, H., Schwartz, M. R., & Mody, D. R. (2019) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2019.01.001 · Cited by 20

Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms

Luo, H., Du, H., Belinson, J. L., & Wu, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220200 · Cited by 20

Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status

van der Waal, D., Bekkers, R. L. M., Dick, S., Lenselink, C. H., Massuger, L. F. A. G., Melchers, W. J. G., Schmeink, C. E., Siebers, A. G., & Broeders, M. J. M. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105927 · Cited by 21

Cancer Screening Interventions in Indigenous Populations: A Rapid Review

Bryant, J., Patterson, K., Vaska, M. M., Chiang, B., Letendre, A., Bill, L., Yang, H., & Kopciuk, K. A. (2021) · Current Oncology · doi:10.3390/curroncol28030161 · Cited by 20

Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials

Zhang, Y., Du, H., Xiao, A., Zhang, W., Wang, C., Huang, X., Qu, X., Wang, J., & Wu, R. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-022-00440-4 · Cited by 20

The Next Steps in Cervical Screening

Sankaranarayanan, R., Qiao, Y., & Keita, N. (2015) · Women s Health · doi:10.2217/whe.14.70 · Cited by 20

Development of a cervical cancer progress prediction tool for human papillomavirus-positive Koreans: A support vector machine-based approach

Kahng, J., Kim, E., Kim, H., & Lee, W. (2015) · Journal of International Medical Research · doi:10.1177/0300060515577846 · Cited by 20

Characterization of novel human papillomavirus types 157, 158 and 205 from healthy skin and recombination analysis in genus γ-Papillomavirus

Bolatti, E. M., Chouhy, D., Casal, P. E., Pérez, G., Stella, E. J., Sánchez, A., Gorosito, M., Bussy, R. F., & Giri, A. A. (2016) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2016.04.018 · Cited by 20

Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing

Pedersen, K., Burger, E. A., Sy, S., Kristiansen, I. S., & Kim, J. J. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.08.231 · Cited by 20

HPV self-testing and cervical cancer screening coverage

Gravitt, P. E., & Rositch, A. F. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70605-3 · Cited by 19

Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study

Benevolo, M., Ronco, G., Mancuso, P., Carozzi, F., De Marco, L., Allia, E., Bisanzi, S., Rizzolo, R., Gustinucci, D., Del Mistro, A., et al. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105149 · Cited by 19

Prevention and control of HPV-related cancers in people living with HIV

Uusküla, A., Tisler, A., DeHovitz, J. A., Murenzi, G., Castle, P. E., & Clifford, G. M. (2025) · The Lancet HIV · doi:10.1016/s2352-3018(25)00011-6 · Cited by 21

Effect of immunotherapy on the immune microenvironment in advanced recurrent cervical cancer

Chen, R., Yang, W., Li, Y., Cheng, X., Nie, Y., Liu, D., & Wang, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108630 · Cited by 19

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer ( HPV FOCAL ) trial

Gottschlich, A., Gondara, L., Smith, L., Cook, D. A., Martin, R. E., Lee, M. H., Peacock, S. J., Proctor, L., Stuart, G. C. E., Krajden, M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34039 · Cited by 19

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study

Inturrisi, F., Rozendaal, L., Veldhuijzen, N. J., Heideman, D. A. M., Meijer, C. J. L. M., & Berkhof, J. H. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004115 · Cited by 19

HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability

Ibáñez, R., Roura, E., Acera, A., Andújar, M., Pavón, M. Á., Bruni, L., & de Sanjosé, S. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107571 · Cited by 19

The end of the decline in cervical cancer mortality in Spain: trends across the period 1981–2012

Cervantes-Amat, M., López‐Abente, G., Aragonés, N., Pollán, M., Pastor‐Barriuso, R., & Pérez‐Gómez, B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1306-x · Cited by 19

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624